KLab has 350 Medical representatives with 60 first line manager and 20 second line manager who cover 90000 Doctors, 50000 Pharmacies and 800 Stockists in India every month. KLab focuses on Gastroenterologists, General Physicians, Orthopaedics, Surgeons, Paediatricians, Diabetologists, Cardiologists Chest Physicians, Gynaecologists etc...  More Details
KLAB has 24 Oncology Executives (EOB’s)  who meet all the Medical Oncologists, Haemato-Oncologists, Radiation Oncologists & Surgical Oncologists in India. They also meet all the Institutions & Government Departments for the Oncology tender business.
 More Details
KLab’s major sales are from patented products from in-house R&D. Cefi-XL our patented antibiotic combination was the No.1 launched new product in India in last 2 years as per July 2006 IMS report (Now sold & patent licensed to NPIL / Abbot).
KLab has over 700 employees. The sales force comprises around 450 persons

 KLab started its global operations in  non-regulated markets for its APIs and Pharma formulations ( Oncology and General).
KLab has presence in 23 countries having registered more than 50 products and more than 200 Dossiers are under registration.

More Details

The individual is at the heart of our creative process. We identify innovative individuals and partner with them.  
   Current openings

WHO-GMP Approved manufacturing facilities

WHO-GMP Approved manufacturing facilities for Oncology, General tablets and cephalosporin.


Regulated Markets

© 2001 - 2007 Khandelwal Laboratories Pvt.Ltd. All rights reserved.